MedTrace Logo

Validation of the English Version of the Drug Hypersensitivity Quality of Life Questionnaire

NCT06523192 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 146

Last updated 2024-07-26

No results posted yet for this study

Summary

We aim to validate the English (UK) translation of the DrHy-Q, and test its reliability in the UK population. This will facilitate for the subsequent economical evaluation of penicillin allergy delabelling.

This research project is part of an MSc in Allergy undertaken by the principal applicant, Dr Patricia Romero, supervised through Imperial College London.

Target population are patients with a drug allergy diagnosed by an Allergist prospectively at the Drug Allergy Clinic.

Is the English version of the Drug Hypersensitivity Quality of Life Questionnaire suitable to be used in the UK population?

Conditions

  • Drug Hypersensitivity
  • Quality of Life

Interventions

OTHER

Questionnaires

No intervention

Sponsors & Collaborators

  • University Hospitals, Leicester

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-21
Primary Completion
2024-05-01
Completion
2024-05-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06523192 on ClinicalTrials.gov